CHA [CHINA TELECOM] 6-K: Page 1.1 Announcement regarding final consideration amount for

[Page 1.1 Announcement regarding final consideration amount for the transaction in relation to the disposal of telecommunications towers and related assets, dated January 29, 2016. A-1 • our business and operating strategies and our ability to successfully execute these strategies; • our network expansion and capital expenditure plans; • our operations and business prospects; • the expected benefit of any]

CHU [CHINA UNICOM (HONG KONG)] 6-K: (Original Filing)

[Number 1 Announcement dated January 29, 2016 in respect of Final Amount of the Transaction Consideration in relation to the Disposal of Telecommunications Towers and related assets. • • changes in the PRC telecommunications industry resulting from the issuance of licenses for telecommunications services by the central government of the PRC;]

By | 2016-03-14T23:28:56+00:00 February 1st, 2016|Categories: Chinese Stocks, CHU, SEC Original|Tags: , , , , , |0 Comments

CHU [CHINA UNICOM (HONG KONG)] 6-K: Number 1 Announcement dated January 29, 2016 in

[Number 1 Announcement dated January 29, 2016 in respect of Final Amount of the Transaction Consideration in relation to the Disposal of Telecommunications Towers and related assets. • • changes in the PRC telecommunications industry resulting from the issuance of licenses for telecommunications services by the central government of the PRC;]

By | 2016-03-14T23:30:58+00:00 February 1st, 2016|Categories: Chinese Stocks, CHU, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Announces Receipt of a Preliminary Non-Binding Proposal

[Sinovac Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company and Formation of Independent Special Committee The Board has formed a special committee consisting of three independent directors (the "Special Committee"), Mr. Simon Anderson, Mr. Yuk Lam Lo and Mr. Meng Mei, to consider the proposal. Mr. Simon Anderson is appointed as the chairman of the Special Committee.] [FORM 6-K -------------- ---------- SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F ___ SINOVAC BIOTECH LTD. 6-K 1 v430208_6k.htm FORM 6-K]

By | 2016-03-16T06:03:08+00:00 February 1st, 2016|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Biotech Announces Issuance of GMP Certificate for EV71 Vaccine BEIJING, January 28, 2016 - Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that the China Food and Drug Administration (“CFDA”) has issued the Good Manufacturing Practices (“GMP”) certificate to Sinovac for the Company's Enterovirus 71 ("EV71") vaccine. This marks the completion of the] []

By | 2016-03-16T06:04:01+00:00 February 1st, 2016|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Biotech Announces Issuance of GMP Certificate for

[Sinovac Biotech Announces Issuance of GMP Certificate for EV71 Vaccine BEIJING, January 28, 2016 - Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that the China Food and Drug Administration (“CFDA”) has issued the Good Manufacturing Practices (“GMP”) certificate to Sinovac for the Company's Enterovirus 71 ("EV71") vaccine. This marks the completion of the] []

By | 2016-03-16T06:05:27+00:00 February 1st, 2016|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar